drugset / Trial / NCT04316013
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
Phase 3
Terminated
254 enrolled
Peter MacCallum Cancer Centre, Australia
Australian and New Zealand College of Anaesthetists · collabNational Health and Medical Research Council, Australia · collabVictorian Comprehensive Cancer Centre · collab
RandomizedParallel-groupSingle-blindOther
Summary
VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival inpatients with either colorectal or non small cell lung cancer.
Timeline
- Start
- 2020-07-31
- Primary completion
- 2025-02-28
- Completion
- 2025-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 1.5 mg/kg | Intravenous |
| Comparator | Propofol | Small molecule | — | Intravenous |
| Comparator | Sevoflurane | Other / unclassified | — | Inhaled |